Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Lægerne ved Havnen, Alment Praktiserende Læger ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   1.9% 1.6% 1.4% 1.7% 1.2% 2.5% 6.0% 6.0%   Credit score (0-100)   71 76 77 71 81 62 13 14   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.9 10.9 26.4 5.3 140.5 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   9,952 10,451 12,233 13,227 15,028 15,275 0.0 0.0   EBITDA   1,888 2,426 1,520 2,127 2,806 1,082 0.0 0.0   EBIT   1,522 1,918 1,017 1,537 2,321 549 0.0 0.0   Pre-tax profit (PTP)   1,512.2 1,908.8 964.7 1,472.9 2,275.8 436.3 0.0 0.0   Net earnings   1,174.1 1,486.2 738.7 1,146.5 1,774.6 339.5 0.0 0.0   Pre-tax profit without non-rec. items   1,512 1,909 965 1,473 2,276 436 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,046 829 3,887 3,372 2,914 2,414 0.0 0.0   Shareholders equity total   1,374 1,686 939 1,346 1,975 539 0.0 0.0   Interest-bearing liabilities   164 307 2,601 2,383 1,253 2,278 171 171   Balance sheet total (assets)   2,668 3,426 5,588 5,848 5,373 4,579 171 171   Net Debt   62.9 -792 2,599 2,379 864 2,268 171 171     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   9,952 10,451 12,233 13,227 15,028 15,275 0.0 0.0   Gross profit growth   5.7% 5.0% 17.1% 8.1% 13.6% 1.6% -100.0% 0.0%   Employees   0 0 0 0 0 21 0 0   Employee growth %   -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   -8,064.0 -8,024.4 -10,712.6 -11,099.7 -12,221.7 -14,192.3 0.0 0.0   Balance sheet total (assets)   2,668 3,426 5,588 5,848 5,373 4,579 171 171   Balance sheet change%   -10.1% 28.4% 63.1% 4.6% -8.1% -14.8% -96.3% 0.0%   Added value   9,586.3 9,942.3 11,730.0 12,637.2 14,542.7 14,741.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -731 -725 2,555 -849 -985 -1,077 -2,414 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   15.3% 18.4% 8.3% 11.6% 15.4% 3.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   54.0% 62.9% 22.6% 26.9% 41.4% 11.0% 0.0% 0.0%   ROI %   91.3% 108.6% 36.8% 38.9% 61.2% 18.2% 0.0% 0.0%   ROE %   83.1% 97.1% 56.3% 100.3% 106.9% 27.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   51.5% 49.2% 16.8% 23.0% 36.8% 11.8% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   3.3% -32.7% 170.9% 111.8% 30.8% 209.6% 0.0% 0.0%   Gearing %   12.0% 18.2% 277.1% 177.0% 63.5% 422.3% 8,570,300.0% 8,570,300.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.0% 3.9% 3.6% 2.6% 2.5% 6.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.2 1.6 0.4 0.7 0.8 0.5 0.0 0.0   Current Ratio   1.2 1.6 0.4 0.7 0.8 0.5 0.0 0.0   Cash and cash equivalent   101.6 1,099.7 2.1 4.5 389.0 10.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   223.6 888.6 -1,822.1 -723.6 -431.1 -1,543.3 -85.7 -85.7   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 702 0 0   Employee expenses / employee   0 0 0 0 0 -676 0 0   EBITDA / employee   0 0 0 0 0 52 0 0   EBIT / employee   0 0 0 0 0 26 0 0   Net earnings / employee   0 0 0 0 0 16 0 0